STOCK TITAN

Global Medical Stock Price, News & Analysis

GMRE NYSE

Welcome to our dedicated page for Global Medical news (Ticker: GMRE), a resource for investors and traders seeking the latest updates and insights on Global Medical stock.

Global Medical REIT Inc. (GMRE) provides essential healthcare infrastructure through its portfolio of specialized medical facilities. This news hub offers investors and industry professionals centralized access to official announcements and market developments.

Track critical updates including property acquisitions, lease agreements with healthcare providers, and financial performance reports. Our curated collection ensures timely access to strategic partnerships, portfolio expansions, and operational milestones that shape this healthcare REIT's trajectory.

All content undergoes strict verification to maintain accuracy and relevance. Users benefit from comprehensive coverage of GMRE's unique position in medical real estate, including its focus on triple-net lease structures and secondary market specialization.

Bookmark this page for efficient monitoring of GMRE's evolving role in healthcare property markets. Combine regular visits with professional financial analysis when making informed decisions about this niche REIT investment.

Rhea-AI Summary

Global Medical REIT (NYSE: GMRE) has declared its 2022 third quarter cash dividend of $0.21 per share for common stock, payable on October 11, 2022. The ex-dividend date is September 23, 2022. Additionally, a cash dividend of $0.46875 per share on its Series A Preferred Stock is scheduled for payment on October 31, 2022, with a record date of October 15, 2022. GMRE focuses on acquiring specialized healthcare facilities and leasing them to prominent healthcare systems.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
dividends
-
Rhea-AI Summary

Global Medical REIT (NYSE: GMRE) reported a net income of $2.2 million or $0.03 per diluted share for Q2 2022, down from $2.6 million or $0.04 per diluted share year-on-year. Funds from Operations (FFO) rose to $16.4 million ($0.24/share), up from $14.1 million ($0.22/share) in Q2 2021. Total revenue increased by 19.2% to $33.7 million due to acquisition activity. The company acquired properties worth $74 million and amended its credit facility to add a $150 million term loan. As of June 30, 2022, portfolio occupancy stood at 96.5%. The company declared a dividend of $0.21 per share for Q2 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.34%
Tags
-
Rhea-AI Summary

Global Medical REIT Inc. (NYSE: GMRE) plans to release its Q2 2022 financial results after market close on August 3, 2022. A conference call to discuss the results will occur on August 4, 2022, at 9:00 a.m. ET. Key executives including Chairman Jeffrey Busch and CFO Robert Kiernan will host the call. Interested parties can access the call via webcast or through a dial-in number. A replay will be available starting at 12:00 p.m. ET on August 4 until midnight on August 18, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
Rhea-AI Summary

Global Medical REIT (NYSE: GMRE) announced the declaration of its second-quarter dividends for 2022. Shareholders will receive a cash dividend of $0.21 per share of common stock on July 8, 2022, with a record date of June 24, 2022. The Series A Preferred Dividend is set at $0.46875 per share, payable on August 1, 2022, with a record date of July 15, 2022. This reflects the company's ongoing commitment to reward its investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.31%
Tags
dividends
-
Rhea-AI Summary

Global Medical REIT (NYSE: GMRE) reported a strong first quarter of 2022, with net income attributable to common stockholders reaching $2.7 million, or $0.04 per diluted share, up from $1.8 million in the same period last year. Total revenue rose by 16.5% year-over-year to $31.9 million, driven by four completed acquisitions totaling $24 million at a 7.2% cap rate. Funds from Operations (FFO) and Adjusted Funds from Operations (AFFO) stood at $16.0 million and $16.8 million, respectively. The company remains well-positioned with approximately $1.4 billion in assets and a solid balance sheet.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.66%
Tags
-
Rhea-AI Summary

Global Medical REIT Inc. (NYSE: GMRE) announced its plans to release first quarter 2022 financial results after market close on May 4, 2022. A conference call to discuss these results will be held on May 5, 2022, at 9:00 a.m. Eastern Time, featuring CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Investors can access the call via a live webcast on the company’s investor website. A replay will be available starting 12:00 p.m. Eastern Time on the same day, lasting until midnight Eastern Time on May 19, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.34%
Tags
Rhea-AI Summary

Global Medical REIT (NYSE: GMRE) has announced its first quarter 2022 cash dividends for common and preferred stock. The common dividend is set at $0.21 per share, payable on April 8, 2022 to stockholders of record by March 25, 2022. Additionally, a quarterly dividend of $0.46875 per share will be paid on Series A Preferred Stock on May 2, 2022, for stockholders recorded by April 15, 2022. GMRE focuses on acquiring and leasing medical office facilities to leading healthcare providers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
dividends
-
Rhea-AI Summary

Global Medical REIT (NYSE: GMRE) reported robust financial results for 2021, with a 23.7% year-over-year revenue increase to $115.9 million. The company achieved a net income of $11.8 million, up from a loss of $7.7 million the previous year. Fourth quarter earnings showed net income of $3.8 million, or $0.06 per diluted share, alongside FFO of $0.23 per share. GMRE invested $196 million in medical real estate, including new acquisitions and expansions, with a weighted average cap rate of 7.6%. The company maintained a strong balance sheet with a leverage ratio of 43% and an unutilized borrowing capacity of $222.5 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.59%
Tags
-
Rhea-AI Summary

Global Medical REIT Inc. (NYSE: GMRE) announced its plan to release fourth quarter and year-end 2021 financial results on February 28, 2022, after market close. A conference call will follow on March 1, 2022, at 9:00 a.m. ET, hosted by CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Participants can access the call via webcast at the company’s investor section or by dialing in. The replay will be available from 12:00 p.m. ET on March 1 to midnight ET on March 15. More information can be found on their official website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags
Rhea-AI Summary

Global Medical REIT (NYSE: GMRE) has released its inaugural Corporate Social Responsibility Report, highlighting its commitment to environmental, social, and governance (ESG) initiatives. The report outlines the Company’s efforts since 2019 to track tenant energy and water usage, achieving a significant increase in participation from 11% to approximately 51%. Additionally, GMRE improved its GRESB assessment score from 21 in 2019 to 42 in 2020. The report emphasizes the Company’s sustainability vision based on alignment, access, and authenticity, showcasing programs to support community health and governance practices focused on integrity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
none

FAQ

What is the current stock price of Global Medical (GMRE)?

The current stock price of Global Medical (GMRE) is $6.28 as of June 16, 2025.

What is the market cap of Global Medical (GMRE)?

The market cap of Global Medical (GMRE) is approximately 422.7M.
Global Medical

NYSE:GMRE

GMRE Rankings

GMRE Stock Data

422.67M
63.10M
5.65%
63.7%
2.01%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
BETHESDA